Bristol-Myers Squibb (BMY) launches its $31/share tender offer to buy Amylin Pharmaceuticals...

|About: Bristol-Myers Squibb Company (BMY)|By:, SA News Editor

Bristol-Myers Squibb (BMY) launches its $31/share tender offer to buy Amylin Pharmaceuticals (AMLN) in a deal that will extend BMY's portfolio of diabetes treatments. The offer will expire on Aug. 7.